Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.1%

2 terminated/withdrawn out of 39 trials

Success Rate

92.6%

+6.1% vs industry average

Late-Stage Pipeline

5%

2 trials in Phase 3/4

Results Transparency

20%

5 of 25 completed trials have results

Key Signals

8 recruiting5 with results

Enrollment Performance

Analytics

Phase 2
7(36.8%)
Phase 1
6(31.6%)
N/A
3(15.8%)
Phase 4
2(10.5%)
Early Phase 1
1(5.3%)
19Total
Phase 2(7)
Phase 1(6)
N/A(3)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (39)

Showing 20 of 39 trials
NCT03458832Active Not Recruiting

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

Role: collaborator

NCT07505342Recruiting

Remote Assessments and Genetic Determinants of Myotonic Dystrophy

Role: collaborator

NCT00272883Recruiting

Molecular and Genetic Studies of Congenital Myopathies

Role: collaborator

NCT03489278Recruiting

Clinical Procedures to Support Research in ALS

Role: collaborator

NCT03639701Phase 1Active Not Recruiting

Treatment of TK2 Deficiency With Thymidine and Deoxycytidine

Role: collaborator

NCT05989620Recruiting

Long-Term Development of Muscular Dystrophy Outcome Assessments

Role: collaborator

NCT05600764Recruiting

The Natural History of TRPV4 Neuropathy

Role: collaborator

NCT01203085Completed

Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT

Role: collaborator

NCT01193075Recruiting

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Role: collaborator

NCT01193088Recruiting

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

Role: collaborator

NCT05412394Phase 4Recruiting

Once Weekly Infant Corticosteroid Trial for DMD

Role: collaborator

NCT03655223Enrolling By Invitation

Early Check: Expanded Screening in Newborns

Role: collaborator

NCT06165172Not ApplicableCompleted

Early Feasibility Study of the MyoRegulator® for Treatment of ALS

Role: collaborator

NCT04193085Completed

Wearable Technology to Assess Gait Function in SMA and DMD

Role: collaborator

NCT03777319Phase 1Terminated

Spironolactone Versus Prednisolone in DMD

Role: collaborator

NCT01938495Phase 2Completed

Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)

Role: collaborator

NCT01783509Completed

Limb Girdle Muscular Dystrophy (LGMD) Natural History

Role: collaborator

NCT02895789Completed

Oxidative Capacity and Exercise Tolerance in Ambulatory SMA

Role: collaborator

NCT00577577Phase 2Completed

Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

Role: collaborator

NCT00790582Phase 2Completed

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Role: collaborator